Alexion Antibody Technologies is Drug Discovery in United States that focus on based biological screening business. Founded in 1997. They cover business area such as developer, antibody drug technology, therapeutic and diagnostic use, drug therapy, combinatorial antibody library development, proprietary selection technology, cell-base biological screening, optimization, animal model development.
1997
( 27 years old in 2024 )
Based Biological Screening
-
3985 Sorrento Valley Boulevard
Suite A
San Diego, CA 92121
United States
Private
developerantibody drug technologytherapeutic and diagnostic usedrug therapycombinatorial antibody library developmentproprietary selection technologycell-base biological screeningoptimizationanimal model development
* We use standard office opening hours in near Alexion Antibody Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Alexion Antibody Technologies is Drug Discovery business from United States that founded in 1997 (27 years old in 2024), Alexion Antibody Technologies business is focusing on Based Biological Screening.
Alexion Antibody Technologies headquarter office and corporate office address is located in 3985 Sorrento Valley Boulevard Suite A San Diego, CA 92121 United States.
Alexion Antibody Technologies was founded in United States.
In 2024, Alexion Antibody Technologies is currently focus on based biological screening sector.
Above is snippet of Google Trends for "based biological screening" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Alexion Antibody Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.